V.K. Fedyaeva

V.K. Fedyaeva

Auto-generated profile, based on publicly available information

V.K. Fedyaeva

Center for Expertise and Quality Control of Medical Care

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2021 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
NMN. Z. Musina
N. Z. Musina
VOV. V. Omelyanovskiy
V. V. Omelyanovskiy
RGR. V. Gostischev
R. V. Gostischev
OSO. A. Sukhorukikh
O. A. Sukhorukikh
VFV. K. Fedyaeva
V. K. Fedyaeva
DSD. G. Shchurov
D. G. Shchurov
Concept of value-based healthcare

1 January 2022 in Medical Technologies. Assessment and Choice
Verified
Journal Article
Open access
VFV.K. Fedyaeva
V.K. Fedyaeva
VOV.V. Omelyanovskiy
V.V. Omelyanovskiy
OSO.A. Sukhorukikh
O.A. Sukhorukikh
ARA.O. Ryzhov
A.O. Ryzhov
AMA.A. Mochalova
A.A. Mochalova
Сахарный диабет (СД) является одной из лидирующих причин смертности населения как в мире, так и в Российской Федерации. По имеющимся данным, терапевтическое обучение пациентов с СД в специально организованных школах является важным и эффективным элементом оказания медицинской помощи, способствует повышению продолжительности и качества жизни пациентов. Данные о клинико-экономической эффективности школ для пациентов с СД (школ диабета — ШД) в Российской Федерации в настоящее время отсутствуют. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить клинико-экономическую целесообразность терапевтического обучения (ШД) взрослых пациентов с СД 1-го и 2-го типа в Российской Федерации. МАТЕРИАЛ И МЕТОДЫ Клинико-экономическое исследование выполнено в марковской модели с использованием анализа «затраты — эффективность». Смоделировано число осложнений СД в зависимости от уровня гликированного гемоглобина у пациентов либо в конце обучения, либо без обучения. Рассчитаны затраты на ШД и госпитализацию в связи с осложнениями СД с позиции системы обязательного медицинского страхования (ОМС) на временнóм горизонте 10 лет. В качестве источников информации для построения модели использованы данные регистра пациентов с СД за 2015—2019 гг., предоставленные ФГБУ «Национальный медицинский исследовательский центр эндокринологии» Минздрава России, а также данные клинических исследований терапевтического обучения пациентов с СД. РЕЗУЛЬТАТЫ Терапевтическое обучение пациентов с СД 1-го и 2-го типа приводит к снижению количества осложнений и смертей и сокращению затрат при периоде моделирования от 5 лет. ЗАКЛЮЧЕНИЕ В настоящем исследовании продемонстрирована клинико-экономическая целесообразность терапевтического обучения (в школе диабета) пациентов при сахарном диабете как 1-го, так и 2-го типа.

21 September 2020 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
VFVlada K. Fediaeva
Vlada K. Fediaeva
EBElena A. Bogova
Elena A. Bogova
VPValentina Peterkova
Valentina Peterkova
OROlga Rebrova
Olga Rebrova
The rapid increase in overweight and obesity in children is a global public health problem. Interventions to reduce the prevalence of obesity before puberty are considered to be the most effective, but the results of trials are not consistent enough. We performed a meta-analysis of the efficacy of interventions to prevent or correct overweight and obesity in pre-pubertal children. Thirty-one Cochrane systematic reviews were analyzed, the results of 10 RCTs and two prospective comparative studies were extracted. All trials had an moderate or high risk of bias. According to the results of meta-analyzes, the prevention of overweight and obesity through recommendations of lifestyle modification is effective, the difference in a BMI decrease is -0.19, 95% CI [-0.35; -0.03], compared with the absence of intervention, in children 78 years old if applied within 24 years, but not within one year or less. The effect of non-drug interventions in children with overweight or obesity was not revealed.

24 May 2025 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
VFV. K. Fediaeva
V. K. Fediaeva
AKA. L. Kalinin
A. L. Kalinin
TKT. T. Knyazeva
T. T. Knyazeva
TVT. A. Vadina
T. A. Vadina
VPValentina Peterkova
Valentina Peterkova
OROlga Rebrova
Olga Rebrova
BACKGROUND: Overweight and obesity in children are associated with diseases in adulthood: metabolic syndrome, type 2 diabetes mellitus, coronary artery disease, hypertension, and some types of cancer. In 2006, WHO initiated the European Childhood Obesity Surveillance Initiative COSI, according to which a survey of Moscow first-graders was conducted in 2017. The Initiative’s publications provided general characteristics of the Russian sample along with those of other countries participating in the Initiative, while the collected Russian data allowed for analysis that is more detailed.AIM: To characterize the population of 7-year-old children in Moscow based on anthropometric parameters and lifestyle indicators.MATERIALS AND METHODS: An epidemiological study was conducted at the National Medical Research Center for Endocrinology of the Russian Ministry of Health in 2017 as part of the COSI program. We examined 7-year-old children studying in one of the 1st grade 68 randomly selected Moscow schools. The study was carried out in accordance with the COSI study protocol, and child, parent and school questionnaire forms were completed. WHO and International Obesity Task Force (IOTF) criteria were used to assess body weight.RESULTS: 2166 children aged 7 years (1068 boys and 1098 girls) were examined. In total, 24.42% of children are overweight or obese according to WHO criteria, 95% CI (22.63%; 26.29%), according to IOTF criteria — 19.21%, 95% CI (17.57%; 20. 93%). 3.0% of children (2.3%; 3.8%) are underweight according to WHO criteria, 2.8% (2.2%; 3.6%) are underweight according to IOTF criteria. The median duration of breastfeeding, (BF) is 8 months, exclusive breastfeeding is 4 months. No relationship was found between the duration of breastfeeding and the child’s weight. Fathers’ BMI is higher than mothers’ BMI. Parents more often believe that their child is normal or underweight than is actually observed. About 2/3 of children go to school on foot or by mechanical transport, participate in sports or dance sections, and spend 1–2 hours a day in outdoor games on weekdays. The duration of reading and preparing lessons on weekdays and weekends does not differ, while the duration of walks on weekends is higher. Screen time on weekends is almost double that on weekdays.CONCLUSION: For the first time, detailed results of an epidemiological study of 7-year-old children in Moscow under the COSI program are presented: assessments of weight, height and other anthropometric indicators, as well as the results of a survey of parents regarding their anthropometric parameters, family history, and children’s lifestyle.

30 December 2021 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
OROlga Rebrova
Olga Rebrova
VFV. K. Fediaeva
V. K. Fediaeva
VAV. A. Aksenov
V. A. Aksenov
BACKGROUND: In evidence-based medicine, the research methodology is determined by the risks of systematic biases and incorrect data analysis. Minimizing both risks increases the internal validity of the study. There are numerous recommendations and guidelines for data analysis and reporting, but the international community has not yet developed a questionnaire for reviewers to assess the quality of statistical analysis.AIM: To develop a tool for formalized assessment of the quality of statistical analysis presented in scientific medical publications.MATERIALS AND METHODS: The questionnaire was developed based on the authors' decades of experience in statistical data analysis and reviewing the statistical aspects of biomedical articles and dissertations. The SAMPL guidelines, ICH E9, and other guidelines were taken into account when developing the questionnaire. Internal validation of the questionnaire was based on an independent assessment by two experts of 20 randomly selected articles on randomized controlled trials (RCTs) from elibrary.ru, and further statistical analysis of the agreement of experts' conclusions.RESULTS: The CORSTAN (CORrect STatistical ANalysis) questionnaire was developed, which consists of two parts: the first part (10 questions) is intended for evaluating studies of any designs, while the second (following eight questions) is for additional assessment of RCTs. A stratification of the risk of incorrect statistical analysis is proposed. The evaluation of the questionnaire's internal validity showed its substantial and almost perfect agreement for each question and each article both in the sum of points and risk level.CONCLUSION: The use of the questionnaire will simplify and harmonize the statistical review of publications and manuscripts in various institutions - scientific journals, dissertation boards, etc. The questionnaire can also be helpful for authors during preparing manuscripts; it will also help improve the quality of publications and research itself. We plan to improve the questionnaire as we gain experience in its application.

23 April 2024 in Medical Technologies. Assessment and Choice
Verified
Journal Article
Closed access
KMK.I. Matryonin
K.I. Matryonin
EKE.O. Kurilovich
E.O. Kurilovich
VFV.K. Fedyaeva
V.K. Fedyaeva
RTR.A. Teryan
R.A. Teryan
Objective. To evaluate clinical efficacy and efficiency of new oral anticoagulants (NOACs) and sodium-glucose cotransporter 2 (SGLT-2) inhibitors in patients with coronary artery disease and concomitant cardiovascular diseases in national healthcare system. Material and methods. The mathematical model assessed clinical efficacy and efficiency of 2 groups of drugs: 1) NOACs (apixaban, dabigatran and rivaroxaban) compared to warfarin in patients with coronary artery disease and atrial fibrillation (AF); 2) SGLT-2 inhibitors (dapagliflozin and empagliflozin) in addition to standard treatment compared to standard treatment without SGLT-2 inhibitors in patients with coronary artery disease and chronic heart failure (CHF) with ejection fraction (EF) <40%. Prediction of all-cause mortality was based on clinical trials after previous systematic searching of appropriate data. We estimated direct medical costs of NOACs and SGLT-2 inhibitors, as well as indirect costs following losses in gross domestic product, cost of prevented death and economic effect per 1 ruble invested. Results. Fewer deaths and higher costs are expected in patients with coronary artery disease and AF receiving NOACs compared to warfarin. The cost of 1 prevented death ranged from 18.75 to 14.63 million rubles. Economic effect per 1 additionally invested ruble for 1, 3 and 7 years was 0.06, 0.124 and 0.267 rubles, respectively. Fewer deaths and higher costs are also assumed in patients with coronary artery disease and CHF (EF <40%) receiving SGLT-2 inhibitors+standard treatment compared to standard treatment alone. The cost of 1 prevented death ranged from 7.93 to 3.81 million rubles. Economic effect per 1 additionally invested ruble for 1, 3 and 7 years was 0.132, 0.271 and 0.583 rubles, respectively. Conclusion. New anticoagulants in patients with coronary artery disease and atrial fibrillation, as well as SGLT-2 inhibitors in patients with chronic heart failure and EF <40% can reduce mortality. Necessary additional costs will be partially offset by lower indirect costs associated with losses in gross domestic product. The cost of prevented death is lower in cohort of patients with coronary artery disease and chronic heart failure receiving SGLT-2 inhibitors compared to patients with coronary artery disease and atrial fibrillation receiving new anticoagulants. Economic effect per 1 ruble invested for SGLT-2 inhibitors exceeds the effect for new anticoagulants.